Monocyte chemoattractant protein-1 mediates collagen deposition in experimental glomerulonephritis by transforming growth factor-β

Abstract

Monocyte chemoattractant protein-1 mediates collagen deposition in experimental glomerulonephritis by transforming growth factor-βbgr;.BackgroundMonocyte chemoattractant protein-1 (MCP-1) plays a significant role in the recruitment of monocytes/macrophages in experimental glomerulonephritis (GN). Because recent evidence points to possible profibrogenic effects of leukocyte-derived factors in GN, this study was designed to evaluate the role of the chemokine MCP-1 in the fibrogenesis of experimental GN.MethodsRats with an anti-thy-1–induced GN were treated with a neutralizing antiserum against MCP-1. Glomerular collagen type IV, as a marker of glomerular matrix deposition, was assessed by Northern and Western blotting and immunohistology. Transforming growth factor-βbgr; (TGF-βbgr;), an important mediator of this matrix expansion, was studied by Northern and Western blotting.ResultsThe induction of GN resulted in a significant increase of glomerular collagen type IV deposition and TGF-βbgr; synthesis. The neutralization of MCP-1 significantly reduced the enhanced collagen type IV protein synthesis and deposition without affecting collagen mRNA expression. However, both the enhanced transcription and protein synthesis of TGF-βbgr; were inhibited by anti–MCP-1 antiserum in nephritic animals.ConclusionsIn this model of GN, MCP-1 has a fibrogenic effect through the stimulation of TGF-βbgr;. MCP-1 is thus not only important for the recruitment of inflammatory cells, but also mediates glomerular matrix accumulation